SYSTEMATIC REVIEW
Published on 20 Dec 2024
Incidence of Hyperkalemia RAASi and SGLT-2i Treatment in Individuals with Diabetic Kidney Disease: A Systematic Review and Network Meta-Analysis
doi 10.3389/fphar.2024.1462965
- Frontiers in Pharmacology
- Renal Pharmacology
- Research Topics
- Diabetic Kidney Disease: Routes to drug development, pharmacology and underlying molecular mechanisms, Volume II
Diabetic Kidney Disease: Routes to drug development, pharmacology and underlying molecular mechanisms, Volume II
4,069
Total Downloads
12k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 06 Dec 2024
FGF21 ameliorates diabetic nephropathy through CDK1dependently regulating the cell cycle
doi 10.3389/fphar.2024.1500458
ORIGINAL RESEARCH
Published on 19 Nov 2024
Shenshuaikang enema restores the intestinal barrier and microbiotagut-kidney axis balance to alleviate chronic kidney disease via NF-kB pathway
doi 10.3389/fphar.2024.1453668
ORIGINAL RESEARCH
Published on 15 Nov 2024
β-cryptoxanthin suppresses oxidative stress via activation of the Nrf2/HO-1 signaling pathway in diabetic kidney disease
doi 10.3389/fphar.2024.1480629
- 340 views
ORIGINAL RESEARCH
Published on 28 Oct 2024
Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut–kidney axis
doi 10.3389/fphar.2024.1424968
- 459 views
ORIGINAL RESEARCH
Published on 22 Oct 2024
Sphagnum cuspidatulum extract prevents acute kidney injury induced by high-fat diet and streptozotocin via alleviation of oxidative stress and apoptosis in pre-diabetic rats
doi 10.3389/fphar.2024.1464463
- 445 views
REVIEW
Published on 04 Oct 2024
Exploring potential targets for natural product therapy of DN: the role of SUMOylation
doi 10.3389/fphar.2024.1432724
- 725 views
ORIGINAL RESEARCH
Published on 29 Aug 2024
Assessment of the effect of the SLC5A2 gene on eGFR: a Mendelian randomization study of drug targets for the nephroprotective effect of sodium-glucose cotransporter protein 2 inhibition
doi 10.3389/fendo.2024.1418575
- 764 views
ORIGINAL RESEARCH
Published on 17 Jul 2024
The role of metabolic memory in diabetic kidney disease: identification of key genes and therapeutic targets
doi 10.3389/fphar.2024.1379821
- 988 views
SYSTEMATIC REVIEW
Published on 04 Jul 2024
Comparative efficacy and safety of SGLT2is and ns-MRAs in patients with diabetic kidney disease: a systematic review and network meta-analysis
doi 10.3389/fendo.2024.1429261
- 1,326 views
ORIGINAL RESEARCH
Published on 30 May 2024
Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis
doi 10.3389/fphar.2024.1362242
- 1,112 views
ORIGINAL RESEARCH
Published on 27 Mar 2024
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study
doi 10.3389/fphar.2024.1358573
- 2,337 views
- 2 citations
Published in
Frontiers in Pharmacology
- Renal Pharmacology
Impact
- 12kTopic views
- 7,339Article views
- 4,069Article downloads